OVATFOvation Science Inc.

About Ovation Science Inc. (OVATF)

Ovation Science Inc. (OVATF) is a Drug Manufacturers - Specialty & Generic company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the Pink tier.

Ovation Science, using its propriatory drug delivery system called INVISICARE, focuses on licensing its topical and transdermal cannabis products to licensed state operators as well as providing private label CBD products to international marketers.Ovation Science is an innovative drug development company with a high performance patented topical and transdermal INVISICARE delivery system; which enhances the delivery of ingredients to and through the skin. Ovation has its own two product lines and licensees along with an international supply agreement. All product are powered by Ovation's proprietary Invisicare technology.

Products and services

Ovation focuses on its topical and transdermal cannabis division all powered by Invisicare skin technology.

OVATF key facts

Ticker symbol

OVATF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

2017

Estimated market cap

$1.17M (as of May 13, 2025)

Shares outstanding

35,244,681

Reporting standard

International Reporting: Canadian Securities Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Quarterly Report (Jun 30, 2024)

Ovation Science Inc. leadership

• Terry Howlett — CEO
• Doreen McMorran — CFO

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with O